Enbrel to be launched in Korea

Wyeth Korea said it plans to launch Enbrel (etanercept) for the treatment of rheumatoid arthritis (RA) from May 29, as the third country in Asia following Australia and Taiwan.

Enbrel is the only biologic therapy approved to reduce signs and symptoms, improve physical function, and inhibit the progression of structural damage in patients with moderately to severely active RA and ankylosing s...